Helicobacter

Papers
(The TQCC of Helicobacter is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort50
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer47
Helicobacter pylori and the intestinal microbiome among healthy school‐age children44
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma44
35
Issue Information33
Helicobacter macacaeMazF interplays with Escherichia coli homologs and enhances antibiotic tolerance31
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection30
Constitutive programmed death ligand 1 expression protects gastric G‐cells from Helicobacter pylori–induced inflammation30
Issue Information28
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis27
New regimens as first‐line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial27
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori27
A case of neonatal thrombocytopenia due to maternal Helicobacter pylori‐associated immune thrombocytopenia26
Helicobacter pylori, gastrointestinal microbiota, and immunotherapy26
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals25
Issue Information23
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis22
Integrin‐Linked Kinase in the Development of Gastric Tumors Induced by Helicobacter pylori: Regulation and Prevention Potential22
Characteristics of Helicobacter pylori Eradication Therapy in Patients 80 Years or Older Living in a Metropolitan Area: A Multicenter Retrospective Study22
Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real‐World Evidence Study22
Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori21
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection21
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor21
Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children20
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes20
Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review20
Eradication rate and adherence with high‐dose amoxicillin and proton pump inhibitor as first‐line treatment for Helicobacter pylori infection: Experience from University Hospital in 20
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug20
Issue Information20
Colloidal bismuth pectin‐containing quadruple therapy as the first‐line treatment of Helicobacter pylori infection: A multicenter, randomized, double‐blind, non‐inferiority clinical trial20
REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 202019
Issue Information19
Ethnic Inequity in the Current Approach to H. pylori Testing and Treatment: Linked Data Cohort Analysis18
Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices17
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota17
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o17
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target17
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults17
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis17
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study17
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis16
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?16
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs16
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice15
Transmission ofHelicobacter pyloribetween a human and two dogs: A case report15
Meta‐analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy15
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project15
CRISPR‐based detection of Helicobacter pylori in stool samples15
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis15
 14
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention14
Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial14
Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis14
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)14
Impact of body size on efficacy of high‐dose dual therapy for Helicobacter pylori eradication13
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting13
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries12
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response12
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions12
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China12
12
Effect ofHelicobacter pylorion immunotherapy is gaining more attention12
Helicobacter pylori enhances HLA‐C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells12
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study11
Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study11
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis11
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China11
Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in11
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 202111
The Accuracy of Melting Curve–Based Multiplex Real‐Time PCR for Diagnosing Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Stool Specimens10
10
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”10
10
Issue Information10
Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship10
Issue Information10
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up10
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection10
10
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis10
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial10
Issue Information10
Combatting Helicobacter pylori: A Focus on Nanomaterials9
Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential9
9
Helicobacter pylori regulated microRNA map of human gastric cells9
The first 5 years of Helicobacter pylori research—With an emphasis on the United Kingdom9
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study9
9
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy9
Corrigendum9
Issue Information9
The association between Helicobacter pylori and gastrointestinal disorders during pregnancy: A Multicenter retrospective study9
Cover Image8
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines8
8
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans8
8
Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR‐30a to regulate COX‐2/BCL9 pathway8
8
Issue Information8
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence8
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia8
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy8
Gastric granulomas and Helicobacter pylori: An incidental relationship8
Antagonizing roles of SHP1 in the pathogenesis of Helicobacter pylori infection8
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article8
0.11121511459351